RE:not planning to use your warrants ????????????You'll have time to buy cheaper shares over the next while. Not sure how much lower it will go bit if the PR of a few weeks ago, is any indication, we could be back into the low 30 cent range while the impatient ones get out and onto something that isn't going to be dead money for 3-6 months, imo.
Spectral Diagnostics Announces Extension of Warrants
TORONTO, Feb. 24, 2014 -Spectral Diagnostics Inc. (TSX: SDI) (OTC QX: DIAGF) (the "Corporation") today announced that its board of directors has approved an extension of the expiry date of the outstanding 24,375,000 common share purchase warrants and 731,250 broker warrants of the Corporation (collectively, the "Warrants") from March 2, 2014 to September 2, 2014. The exercise price of the Warrants remains unamended at $0.60 and no other changes were made to the terms of the Warrants. The Warrants were issued in connection with a previous financing of the Corporation.
The conditional approval of the TSX has been obtained for the extension of the Warrants, subject in the case of the 7,552,644 Warrants held by insiders of the Corporation, to the approval of disinterested shareholders of the Corporation ("Shareholders") at the next annual and special meeting of Shareholders expected to be held on May 27, 2014. The 17,553,606 Warrants held by non-insiders are not subject to the approval of Shareholders and will continue to be exercisable after their original expiry date from March 10, 2014 (being the expiry of the 10 day notice period mandated by the TSX) until September 2, 2014. The extension of the Warrants is also subject to the Corporation satisfying the customary conditions specified in the TSX conditional approval letter.
The board of directors of the Corporation approved the extension of the expiry date of the Warrants following the recent announcement by the Corporation that the Data Safety Monitoring Board has recommended continuation of the Corporation's EUPHRATES trial and requested that the contract research organization conduct some additional analysis before it provides further guidance to the Corporation. That analysis is in process but has not yet been completed.